Central AsianResearch Index

IMPACT OF GENOME SEQUENCING IN THE TREATMENT OF TOTALLY DRUG-RESISTANT TUBERCULOSIS: A CASE REPORT

ВЛИЯНИЕ ИСПОЛЬЗОВАНИЯ ГЕНОМНОГО СЕКВЕНИРОВАНИЯ В ТЕРАПИИ БОЛЬНОГО ТУБЕРКУЛЁЗОМ С ТОТАЛЬНОЙ ЛЕКАРСТВЕННОЙ УСТОЙЧИВОСТЬЮ: КЛИНИЧЕСКИЙ СЛУЧАЙ

Totally drug-resistant tuberculosis (TDR-TB) is an extremely severe clinical phenotype characterized by resistance to all first-line and virtually all second-line anti-TB agents. Advances in whole-genome sequencing (WGS) offer critical opportunities to map comprehensive resistance profiles and rapidly optimize individualized therapeutic regimens. This case report describes the successful management of a patient with TDR-TB. The initial presentation was diagnosed as infiltrative pulmonary tuberculosis in the destruction (lysis) phase, confirmed via GeneXpert MTB/Rif. The baseline diagnostic workup followed national clinical guidelines. It included chest radiography, GeneXpert testing, complete blood counts, screening for HIV, HBsAg, and anti-HCV antibodies, and routine urinalysis and stool examinations. Second-line anti-TB therapy was initiated in an inpatient setting and transitioned to outpatient care; however, the patient experienced multiple episodes of non-adherence and loss to follow-up. Subsequent drug susceptibility testing and whole-genome sequencing identified Mycobacterium tuberculosis complex (Beijing lineage) with resistance to rifampin, ethambutol, pyrazinamide, levofloxacin, moxifloxacin, linezolid, streptomycin, and ethionamide. Notably, susceptibility to bedaquiline, clofazimine, delamanid, amikacin, capreomycin, and pretomanid was preserved. The therapeutic regimen was adjusted dynamically based on these genomic insights, ultimately resulting in a favorable definitive outcome (treatment outcome: "cured"). This case underscores the clinical utility of genomic sequencing in managing highly resistant tuberculosis, emphasizing its pivotal role in designing effective, individualized treatment regimens within resource-limited settings. Keywords: Tuberculosis, total drug resistance, genomic sequencing, individualized treatment, case report.

Сведения

Журнал
Avicenna Bulletin
Опубликовано
2026 · Т. 28, № 3, С. 879-886
Язык
Английский
ISSN
2074-0581 · 2959-6327
Издатель
Avicenna Tajik State Medical University
Аффилиации
Department of Phthisiopulmonology, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan
Department of Epidemiology, Hygiene and Environmental Protection with a Course in Microbiology and Virology, Institute of Postgraduate Education in Healthcare of the Republic of Tajikistan, Dushanbe, Republic of Tajikistan